Skip to main content
Back to Felicis

Felicis's Pharmaceutical Portfolio

Browse 8 Pharmaceutical companies funded by Felicis. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
8
Total Funding in Pharmaceutical
$843.5M

Pharmaceutical Portfolio Companies (8)

Export
Artificial Intelligence (AI)BiotechnologyMachine LearningPharmaceuticalSoftwareTherapeutics

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

Salt Lake City, United States
June 2024
$200.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Health CareMedicalMobilePharmaceutical

Nimble provides a pharmacy experience centered around the patient's needs to provide a more streamlined workflow.

Redwood City, United States
June 2022
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

ProteinQure is a biotech company that designs peptide-based therapeutics and drug delivery systems using AI.

Toronto, Canada
May 2026
$1.8M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsLife ScienceOncologyPharmaceutical

Xilis is an oncology and precision health company that provides technologies to diagnoses cancer.

Durham, United States
April 2025
$19.4M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Health CareMedicalPharmaceutical

Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients.

Menlo Park, United States
January 2026
$250.0M
Series F

Founder Contacts

30,000+ verified contacts

Health CareHealth InsuranceLife InsurancePharmaceutical

Health IQ is an insurance provider with affordable insurance rates based on customers lifestyle.

Mountain View, United States
January 2022
$287K
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyClinical TrialsHealth CareMedicalPharmaceutical

Formation Bio is a drug development company that strives to provide treatments to patients faster by reimagining clinical trials.

New York, United States
June 2024
$372.0M
Series D

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareLife SciencePharmaceutical

Spring Discovery accelerates the discovery of therapies for aging by targeting the biological processes of aging itself.

Palo Alto, United States
January 2021
Series B

Founder Contacts

30,000+ verified contacts

Explore Felicis's Full Portfolio

View all companies funded by Felicis across every industry and funding stage.

View Full Felicis Portfolio